JAMA Online First: Prevention of DTE in Patients With Cancer; Mifepristone and the FDA; Perfusion in Organ Transplants

Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@jamanetwork.org.

To sign up for additional alerts, or to unsubscribe, click here. 

To ensure you always receive JAMA Network emails, add the email address updates@jamanetwork.org to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.

©2023 American Medical Association. All rights reserved.